OnKure Therapeutics, Inc. (OKUR) Stock Ticker
Market factors today
Unlock the full OKUR picture
About OnKure Therapeutics, Inc.
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
OKUR stock facts
| Ticker symbol | OKUR |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $106.5M |
| CEO | Nicholas A. Saccomano |
| Employees | 45 |
| Headquarters | Boulder, CO, US |
| IPO date | 2021-04-08 |
| Website | onkuretherapeutics.com |
What you can see for OKUR on Tickr
Live OKUR price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the OKUR report.
Rankings
FAQ
What is the ticker symbol for OnKure Therapeutics, Inc.?
The ticker symbol for OnKure Therapeutics, Inc. is OKUR, listed on the NASDAQ Global Market.
What is OKUR?
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide…